1. Independent UK Panel on Breast Cancer Screening, The benefits and harms of breast cancer screening: an independent review. The Lancet, 2012. 380(9855): p. 1778-1786.
2. Macmillan Cancer Support -NHS, Deprivation and Survival from Breast Cancer in Scotland. 2017.
3. Jang, B.-S. and J.H. Chang, Socioeconomic status and survival outcomes in elderly cancer patients: A national health insurance service-elderly sample cohort study. Cancer Medicine, 2019. 8(7): p. 3604-3613.
4. Pruitt, S.L., et al., Association of Area Socioeconomic Status and Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review. Cancer Epidemiology Biomarkers &amp; Prevention, 2009. 18(10): p. 2579.
5. Schrijvers, C.T., et al., Deprivation and survival from breast cancer. British journal of cancer, 1995. 72(3): p. 738-743.
6. Woods, L.M., et al., Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006. Int J Cancer, 2016. 138(10): p. 2396-403.
7. Mullooly, M., et al., Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues. European Journal of Cancer, 2017. 86: p. 326-333.
8. Engstrøm, M.J., et al., Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients. Breast Cancer Research and Treatment, 2013. 140(3): p. 463-73.
9. Fallahpour, S., et al., Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ open, 2017. 5(3): p. E734-E739.
10. Howlader, N., et al., Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiology, Biomarkers and Prevention, 2018. 27(6): p. 619-626.
11. Anderson, W.F., H.A. Katki, and P.S. Rosenberg, Incidence of breast cancer in the United States: current and future trends. Journal of the National Cancer Institute, 2011. 103(18): p. 1397-402.
12. Johansson, A.L.V., et al., Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer, 2019. 144(6): p. 1251-1261.
13. Bastiaannet, E., et al., Socioeconomic differences in survival among breast cancer patients in the Netherlands not explained by tumor size. Breast Cancer Res Treat, 2011. 127(3): p. 721-7.
14. Cross, C.K., J. Harris, and A. Recht, Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer, 2002. 95(9): p. 1988-99.
15. Rutqvist, L.E. and A. Bern, Socioeconomic gradients in clinical stage at presentation and survival among breast cancer patients in the Stockholm area 1977-1997. Int J Cancer, 2006. 119(6): p. 1433-9.
16. Bauer, K.R., et al., Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 2007. 109(9): p. 1721-8.
17. Thomson, C.S., et al., Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. Journal of epidemiology and community health, 2001. 55(5): p. 308-15.
18. Vona-Davis, L. and D.P. Rose, The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. Journal of Womens Health, 2009. 18(6): p. 883-93.
19. Amirikia, K.C., et al., Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations. Cancer, 2011. 117(12): p. 2747-53.
20. Carey, L.A., et al., Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA, 2006. 295(21): p. 2492-2502.
21. Clarke, C.A., et al., Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover. JNCI: Journal of the National Cancer Institute, 2012. 104(14): p. 1094-1101.
22. Gluz, O., et al., Triple-negative breast cancer--current status and future directions. Ann Oncol, 2009. 20(12): p. 1913-27.
23. Mesa-Eguiagaray, I., et al., Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data. Br J Cancer, 2020. 123(5): p. 852-859.
24. ISD- NHS Scotland. National Cancer Registration Data Definitions Version 14.4. 2017; Available from: https://www.isdscotland.org/Health-Topics/Cancer/Scottish-Cancer-Registry/Cancer-Metadata/_docs/Cancer-Registration-Definitions-v14-4.pdf.
25. Perou, C.M., et al., Molecular portraits of human breast tumours. Nature, 2000. 406(6797): p. 747.
26. GDP Team-NHS National Services Scotland, Deprivation Guidance for analysts, Public Health & Intelligence, Editor. 2019: https://www.isdscotland.org/Products-and-Services/GPD-Support/Deprivation/_docs/PHI-Deprivation-Guidance-version-3-2.pdf.
27. Kendrick, S. and J. Clarke, The Scottish Record Linkage System. Health bulletin, 1993. 51(2): p. 72-79.
28. Public Health Scotland. Scottish Cancer Registry- cancer metadata. Data and Intelligence 2020 [cited 2020.
29. Skyrud, K.D., F. Bray, and B. Møller, A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis. International Journal of Cancer, 2014. 135(1): p. 196-203.
30. National records of Scotland. Mid-Year Population Estimates. 2019 [cited 2019; Available from: https://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/population/population-estimates/mid-year-population-estimates.
31. National Records of Scotland, Mid-2018 Population Estimates for Scotland: Methodology Guide. 2019.
32. Clegg, L.X., et al., Estimating average annual per cent change in trend analysis. Stat Med, 2009. 28(29): p. 3670-82.
33. Kaplan, E.L. and P. Meier, Nonparametric estimation from incomplete observations. Journal of the American statistical association, 1958. 53(282): p. 457-481.
34. NHS Scotland, Breast cancer clinical quality performance indicators, Scottish cancer taskforce national cancer quality steering group, Editor. 2016.
35. Cox, D.R., Regression Models and Life-Tables. Journal of the Royal Statistical Society. Series B (Methodological), 1972. 34(2): p. 187-220.
36. Charlson, M.E., et al., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987. 40(5): p. 373-83.
37. Public Health Scotland. Scottish breast screening pogramme statistics 2018/2019. 2019; Available from: https://www.isdscotland.org/Health-Topics/Cancer/Publications/2017-04-25/2017-04-25-SBSP-Cancer-Report.pdf.
38. Harper, S., et al., Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiology and Prevention Biomarkers, 2009. 18(1): p. 121-131.
39. Sprague, B.L., et al., Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer, 2011. 117(7): p. 1542-51.
40. Cheong, C.K., et al., The Scottish Health Survey 2018 edition; amended in February 2020: Volume 1, Main report. 2020.
41. Traversy, G. and J.-P. Chaput, Alcohol Consumption and Obesity: An Update. Current obesity reports, 2015. 4(1): p. 122-130.
42. Tod, E., et al., Obesity in Scotland: a persistent inequality. International journal for equity in health, 2017. 16(1): p. 135-135.
43. Stockton, D. and J. McCann, Cancer registries in monitoring, evaluating and planning breast cancer screening programmes. Evaluation and Monitoring of Screening Programmes. Luxembourg: Office for Official Publications of the European Communities., 2001: p. 181-94.
44. Tunstall, R. and R. Lupton, Is Targeting Deprived Areas an Effective Means to Reach Poor People? An Assessment of One Rationale for Area-Based Funding Programmes, CASE/70. London: London School of Economics and Political Science. 2003.
45. Robson, B., et al., Deprivation in London: an alternative to IMD 2000. Manchester: University of Manchester, 2001.